173 related articles for article (PubMed ID: 36614290)
1. Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review.
Ge Q; Liu Y; Yang F; Sun G; Guo J; Sun S
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614290
[TBL] [Abstract][Full Text] [Related]
2. Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.
Farag S; van der Kolk LE; van Boven HH; van Akkooi ACJ; Beets GL; Wilmink JW; Steeghs N
Fam Cancer; 2018 Apr; 17(2):247-253. PubMed ID: 28710566
[TBL] [Abstract][Full Text] [Related]
3. Novel c-KIT germline mutation in a family with gastrointestinal stromal tumors and cutaneous hyperpigmentation.
Carballo M; Roig I; Aguilar F; Pol MA; Gamundi MJ; Hernan I; Martinez-Gimeno M
Am J Med Genet A; 2005 Feb; 132A(4):361-4. PubMed ID: 15742474
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis, Treatment, and Prognosis of Patients with Primary Familial Gastrointestinal Stromal Tumor: A Case Report and Literature Review.
Yan M; Lin J; Shu M; Luo Y; Sun K; Yang S; Zhang X
Oncologist; 2023 Dec; 28(12):e1134-e1141. PubMed ID: 37311038
[TBL] [Abstract][Full Text] [Related]
5. Familial gastrointestinal stromal tumors, lentigines, and café-au-lait macules associated with germline c-kit mutation treated with imatinib.
Gupta D; Chandrashekar L; Larizza L; Colombo EA; Fontana L; Gervasini C; Thappa DM; Rajappa M; Rajendiran KS; Sreenath GS; Kate V
Int J Dermatol; 2017 Feb; 56(2):195-201. PubMed ID: 28074523
[TBL] [Abstract][Full Text] [Related]
6. Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene.
Maeyama H; Hidaka E; Ota H; Minami S; Kajiyama M; Kuraishi A; Mori H; Matsuda Y; Wada S; Sodeyama H; Nakata S; Kawamura N; Hata S; Watanabe M; Iijima Y; Katsuyama T
Gastroenterology; 2001 Jan; 120(1):210-5. PubMed ID: 11208730
[TBL] [Abstract][Full Text] [Related]
7. Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS).
Du J; Wang S; Wang R; Wang SY; Han Q; Xu HT; Yang P; Liu Y
Pathol Oncol Res; 2020 Jan; 26(1):91-100. PubMed ID: 31758409
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
9. A novel germline KIT mutation (p.L576P) in a family presenting with juvenile onset of multiple gastrointestinal stromal tumors, skin hyperpigmentations, and esophageal stenosis.
Neuhann TM; Mansmann V; Merkelbach-Bruse S; Klink B; Hellinger A; Höffkes HG; Wardelmann E; Schildhaus HU; Tinschert S
Am J Surg Pathol; 2013 Jun; 37(6):898-905. PubMed ID: 23598963
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous hyperpigmentation and familial gastrointestinal stromal tumour associated with KIT mutation.
Wali GN; Halliday D; Dua J; Ieremia E; McPherson T; Matin RN
Clin Exp Dermatol; 2019 Jun; 44(4):418-421. PubMed ID: 30280421
[TBL] [Abstract][Full Text] [Related]
11. Practical role of mutation analysis for imatinib treatment in patients with advanced gastrointestinal stromal tumors: a meta-analysis.
Zhi X; Zhou X; Wang W; Xu Z
PLoS One; 2013; 8(11):e79275. PubMed ID: 24223922
[TBL] [Abstract][Full Text] [Related]
12. Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.
Li FP; Fletcher JA; Heinrich MC; Garber JE; Sallan SE; Curiel-Lewandrowski C; Duensing A; van de Rijn M; Schnipper LE; Demetri GD
J Clin Oncol; 2005 Apr; 23(12):2735-43. PubMed ID: 15837988
[TBL] [Abstract][Full Text] [Related]
13. Extracellular domain c-kit mutation with duplication of Ser501Ala502 found in gastrointestinal stromal tumors is more imatinib- and nilotinib-sensitive than that with duplication of Ala502Tyr503.
Liu NN; Ohkouchi M; Hashikura Y; Kajimoto N; Matsuda I; Isozaki K; Toh Y; Takahashi T; Nishida T; Hirota S
Lab Invest; 2013 May; 93(5):502-7. PubMed ID: 23459373
[TBL] [Abstract][Full Text] [Related]
14. Familial and multiple gastrointestinal stromal tumors with fair response to a half-dose of imatinib.
Bamba S; Hirota S; Inatomi O; Ban H; Nishimura T; Shioya M; Imaeda H; Nishida A; Sasaki M; Murata S; Andoh A
Intern Med; 2015; 54(7):759-64. PubMed ID: 25832938
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
16. Spectrum of activity of dasatinib against mutant KIT kinases associated with drug-sensitive and drug-resistant gastrointestinal stromal tumors.
Zeng C; Zhu L; Jia X; Pang Y; Li Z; Lu X; Xie F; Duan L; Wang Y
Gastric Cancer; 2020 Sep; 23(5):837-847. PubMed ID: 32291709
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia.
Robson ME; Glogowski E; Sommer G; Antonescu CR; Nafa K; Maki RG; Ellis N; Besmer P; Brennan M; Offit K
Clin Cancer Res; 2004 Feb; 10(4):1250-4. PubMed ID: 14977822
[TBL] [Abstract][Full Text] [Related]
18. Multiple gastrointestinal stromal tumors caused by a novel germline KIT gene mutation (Asp820Gly): a case report and literature review.
Arima J; Hiramatsu M; Taniguchi K; Kobayashi T; Tsunematsu I; Kagota S; Sakane J; Suzuki Y; Hirota S
Gastric Cancer; 2020 Jul; 23(4):760-764. PubMed ID: 32146645
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Gao J; Li J; Li Y; Li Z; Gong J; Wu J; Liu N; Dong B; Qi C; Li J; Shen L
Oncotarget; 2016 May; 7(21):30241-9. PubMed ID: 26848617
[TBL] [Abstract][Full Text] [Related]
20. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
Lasota J; Miettinen M
Semin Diagn Pathol; 2006 May; 23(2):91-102. PubMed ID: 17193822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
